Loading...

DyLight™ 488 Goat anti-hamster (Armenian) IgG Antibody

Pricing & Availability
Clone
Poly4055 (See other available formats)
Regulatory Status
RUO
Isotype
Goat Polyclonal IgG
Ave. Rating
Submit a Review
Product Citations
publications
Compare all formats
Cat # Size Price Save
405503 100 µg ¥23,320
Description

This polyclonal antibody reacts with the heavy chains of IgG and the light chains common to most immunoglobulins from Armenian hamster. No cross-reactivity has been detected against non-immunoglobulin serum proteins. This antibody has been solid-phase absorbed to ensure minimal cross-reaction with mouse, rat, human, bovine, and rabbit immunoglobulins, but may cross-react with Armenian hamster IgM and Syrian hamster immunoglobulins.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Armenian Hamster
Antibody Type
Polyclonal
Host Species
Goat
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography, and conjugated with DyLight™ 488 under optimal conditions.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.5 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

* DyLight™ 488  has a maximum absorption of 493nm and a maximum emission of 518 nm (similar to Alexa Fluor® 488 or FITC).

Application Notes

This conjugated goat anti-hamster IgG antibody is useful for immunofluorescent staining with flow cytometric analysis or microscopy.

Product Citations
  1. Jeon H, et al. 2021. Neurotherapeutics. 18:2692. PubMed
  2. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  3. Xu X, et al. 2018. Cell. 175:1336. PubMed
  4. Sakurai Y, et al. 2018. Mol Ther Oncolytics. 11:102. PubMed
  5. Leppin K, et al. 2014. Invest Ophthalmol Vis Sci . 55:3603. PubMed
  6. Crespo J, et al. 2017. Oncoimmunology. 6:e1362529. PubMed
RRID
AB_1575117 (BioLegend Cat. No. 405503)
Go To Top Version: 4    Revision Date: 01/26/2021

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account